Chattem, Inc. a leading marketer and manufacturer of branded consumer products, today announced the closing of its previously announced agreement to acquire the U.S. rights to five leading consumer and over-the-counter brands from Johnson & Johnson for $410 million in cash. With the acquisition, Chattem’s diverse portfolio of high quality brands has now been expanded to include the following additional brands: Act, an anti-cavity mouthwash/mouth rinse; Uunisom, an OTC sleep aid; Co...